Diane E. Brattain
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 9
- Cancer Cells and Metastasis 5
- Peptidase Inhibition and Analysis 3
-
- Bioactive Compounds and Antitumor Agents 3
- Co-authors
- Michael G. Brattain (19 shared papers)Jerry N. Thompson (1 shared paper)Alan E. Levine (7 shared papers)Naseema M. Hoosein (6 shared papers)Kathleen M. Mulder (3 shared papers)Michael Marks (3 shared papers)Douglas D. Boyd (2 shared papers)Subhas Chakrabarty (4 shared papers)
- Journals
- Cancer Letters (3 papers)Experimental Cell Research (2 papers)Biochemical and Biophysical Research Communications (1 paper)Regulatory Peptides (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Diane E. Brattain
19 papers receiving 1.1k citations
Diane E. Brattain's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 500
- Cancer Research 222
- Immunology and Allergy 83
- Biotechnology 97
- Toxicology 37
Countries citing papers authored by Diane E. Brattain
This map shows the geographic impact of Diane E. Brattain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane E. Brattain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane E. Brattain more than expected).
Fields of papers citing papers by Diane E. Brattain
This network shows the impact of papers produced by Diane E. Brattain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane E. Brattain. The network helps show where Diane E. Brattain may publish in the future.
Co-authors
The 16 scholars most cited alongside Diane E. Brattain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Heterogeneity of malignant cells from a human colonic carcinoma. Hit paper breakdown → | 1981 | 428 |
| 2 | 1989 | 132 | |
| 3 | Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts. | 1981 | 82 |
| 4 | Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line. | 1987 | 72 |
| 5 | 1983 | 63 | |
| 6 | Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose. | 1988 | 59 |
| 7 | 1988 | 59 | |
| 8 | 1988 | 48 | |
| 9 | Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line. | 1988 | 36 |
| 10 | Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material. | 1988 | 30 |
| 11 | Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells. | 1985 | 29 |
| 12 | 1982 | 28 | |
| 13 | Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations. | 1984 | 27 |
| 14 | Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line. | 1985 | 25 |
| 15 | 1988 | 25 | |
| 16 | Effects of mitomycin on human colon carcinoma cells. | 1984 | 19 |
| 17 | 1989 | 13 | |
| 18 | 1988 | 13 | |
| 19 | 1986 | 10 |
About Diane E. Brattain
Diane E. Brattain is a scholar working on Oncology, Toxicology, Cancer Research, Molecular Biology and Genetics, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), TGF-β signaling in diseases (4 papers), Peptidase Inhibition and Analysis (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Cancer therapeutics and mechanisms (3 papers), Cancer Research and Treatments (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). The work is most often cited by research in Oncology (500 citations), Cancer Research (222 citations), Immunology and Allergy (83 citations), Biotechnology (97 citations) and Toxicology (37 citations). Diane E. Brattain has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Michael G. Brattain, Jerry N. Thompson, Alan E. Levine, Naseema M. Hoosein, Kathleen M. Mulder, Michael Marks, Douglas D. Boyd, Subhas Chakrabarty, James K. V. Willson and Byron H. Long. Their work appears in journals such as Cancer Letters, Experimental Cell Research, Biochemical and Biophysical Research Communications, Regulatory Peptides and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.